IDEAS home Printed from https://ideas.repec.org/a/eee/worpat/v26y2004i2p123-129.html
   My bibliography  Save this article

A balancing act in the United States Drug Industry: pioneer and generic drugs, the Orange Book, marketing protection and the US consumer

Author

Listed:
  • Holovac, Mary Ann

Abstract

This article reviews the range of laws and requirements that surround the creation, testing and marketing of pharmaceutical materials in the USA. It focuses in particular on the Orange Book--more formally Approved Drug Products with Therapeutic Equivalence Evaluations--and its role in the process of providing safe and effective drugs at reasonable cost for the consumer, while ensuring that the corresponding research and development in creating new drug products is rewarded. Specific topics covered include: the history and purpose of the 'Orange Book', the legislative background, safety and effectiveness, therapeutic equivalence, Waxman-Hatch legislation, the patent position, various forms of exclusivity of marketing rights--such as orphan, Waxman-Hatch, and pediatric, and patent certification as part of an abbreviated new drug application.

Suggested Citation

  • Holovac, Mary Ann, 2004. "A balancing act in the United States Drug Industry: pioneer and generic drugs, the Orange Book, marketing protection and the US consumer," World Patent Information, Elsevier, vol. 26(2), pages 123-129, June.
    • Handle: RePEc:eee:worpat:v:26:y:2004:i:2:p:123-129
    as

    Download full text from publisher

    File URL: http://www.sciencedirect.com/science/article/pii/S0172-2190(03)00179-0
    Download Restriction: Full text for ScienceDirect subscribers only
    ---><---

    As the access to this document is restricted, you may want to search for a different version of it.

    Citations

    Citations are extracted by the CitEc Project, subscribe to its RSS feed for this item.
    as


    Cited by:

    1. Hazel V. J. Moir, 2016. "Exploring Evergreening: Insights from Two Medicines," Australian Economic Review, The University of Melbourne, Melbourne Institute of Applied Economic and Social Research, vol. 49(4), pages 413-431, December.

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:eee:worpat:v:26:y:2004:i:2:p:123-129. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    We have no bibliographic references for this item. You can help adding them by using this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Catherine Liu (email available below). General contact details of provider: http://www.elsevier.com/wps/find/journaldescription.cws_home/654/description#description .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.